Upregulation of proinflammatory cytokines in the fetal brain of the Gaucher mouse

Journal of Korean Medical Science

Volumn 21, Issue 4, 2006, Pages 733-738

  Young, Bin Hong ^a   Eun, Young Kim ^a   Jung, Sung Chul ^a  

^a Ewha Womans University School of Medicine   (South Korea)

Author keywords

Brain; Cytokines; Gaucher Disease; Glucocerebrosidase; Glucosylceramidase; Mice; Models, Animal; Nitric Oxide

Indexed keywords

EID: 33746868262     PISSN: 10118934     EISSN: 15986357     Source Type: Journal    
DOI: 10.3346/jkms.2006.21.4.733     Document Type: Article

References (35)

1. Beutler E, Grabowski GA. Gaucher disease. In: Scriver CR, Beaudet AL, Sly WS, Valle D, editors, The Metabolic and Molecular Bases of Inherited Disease. New York: McGraw-Hill 2001: 3635-68.
2. Brady RO, Kanfer JN, Bradley RM, Shapiro D. Demonstration of a deficiency of glucocerebroside-cleaving enzyme in Gaucher's disease. J Clin Invest 1966; 45: 1112-5.
3. Brady RO, Barton NW, Grabowski GA. The role of neurogenetics in Gaucher disease. Arch Neurol 1993; 50: 1212-24.
4. Hong YB, Kim EY, Jung SC. Down regulation of Bcl-2 in the fetal brain of Gaucher disease mouse model: a possible role in the neuronal loss. J Hum Genet 2004; 49: 349-54.
5. Barak V, Acker M, Nisman B, Kalickman I, Abrahamov A, Zimran A, Yatziv S. Cytokines in Gaucher's disease. Eur Cytokine Netw 1999; 10: 205-10.
6. Lichtenstein M, Zimran A, Horowitz M. Cytokine mRNA in Gaucher disease. Blood Cell Mol Dis 1997; 23: 395-401.
7. Mizukami H, Mi Y, Wada R, Kono M, Yamashita T, Liu Y, Werth N, Sandhoff R, Sandhoff K, Proia RL. Systemic inflammation in glucocerebrosidase-deficient mice with minimal glucosylceramide storage. J Clin Invest 2002; 109: 1215-21.
8. Baudry M, Yao Y, Simmons D, Liu J, Bi X. Postnatal development of inflammation in a murine model of Niemann-Pick type C disease: immunohistochemical observations of microglia and astroglia. Exp Neurol 2003; 184: 887-903.
9. Jeyakumar M, Thomas R, Elliot-Smith E, Smith DA, van der Spoel AC, d'Azzo A, Perry VH, Butters TD, Dwek RA, Platt FM. Central nervous system inflammation is a hallmark of pathogenesis in mouse models of GM1 and GM2 gangliosidosis. Brain 2003; 126: 974-87.
10. Wu YP, Proia RL. Deletion of macrophage-inflammatory protein 1 retards neurodegeneration in Sandhoff disease mice. Proc Natl Acad Sci USA 2004; 101: 8425-30.
11. Tybulewicz VL, Tremblay ML, LaMarca ME, Willemsen P, Stubblefield BK, Winfield S, Zablocka B, Sidransky E, Martin BM, Huang SP, Mintzer KN, Westphal H, Mulligan RO, Ginns EI. Animal model of Gaucher's disease from targeted disruption of the mouse glucocerebrosidase gene. Nature 1992; 357: 407-10.
12. Min KJ, Yang MS, Jou I, Joe EH. Protein kinase A mediates microglial activation induced by plasminogen and gangliosides. Exp Mol Med 2004; 36: 461-7.
13. Pelled D, Shogomori H, Futerman AH. The increased sensitivity of neurons with elevated glucocerebroside to neurotoxic agents can be reversed by imiglucerase. J Inherit Metab Dis 2000; 23: 175-84.
14. Ding AH, Nathan CF, Stuehr DJ. Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages: comparison of activating cytokines and evidence for independent production. J Immunol 1988; 141: 2407-12.
15. Korkotian E, Schwarz A, Pelled D, Schwarzmann G, Segal M, Futerman AH. Elevation of intracellular glucosylceramide levels results in an increase in endoplasmic reticulum density and in functional calcium stores in cultured neurons. J Biol Chem 1999; 274: 21673-8.
16. Orvisky E, Park JK, LaMarca ME, Ginns EI, Martin BM, Tayebi N, Sidransky E. Glucosylsphingosine accumulation in tissues from patients with Gaucher disease: Correlation with phenotype and genotype. Mol Genet Metab 2002; 76: 262-70.
17. Orvisky E, Sidransky E, McKinney CE, LaMarca ME, Samimi R, Krasnewich D, Martin BM, Ginns EI. Glucosylsphingosine accumulation in mice and patients with type 2 Gaucher disease begins early in gestation. Pediatr Res 2000; 48: 233-7.
18. Lloyd-Evans E, Pelled D, Riebeling G, Futerman AH. Lyso- glycosphingolipids mobilize calcium from brain microsomes via multiple mechanisms. Biochem J 2003; 375: 561-5.
19. Schueler UH, Kolter T, Kaneski CR, Blusztajn JK, Herkenham M, Sandhoff K, Brady RO. Toxicity of glucosylsphingosine to cultured neuronal cells: a model system for assessing neuronal damage in Gaucher disease type 2 and 3. Neurobiol Dis 2003; 14: 595-601.
20. Raas-Rothschild A, Pankova-Kholmyansky I, Kacher Y, Futerman AH. Glycosphingolipidoses: beyond the enzymatic defect. Glycoconj J 2004; 21: 295-304.
21. Shoenfeld Y, Gallant LA, Shaklai M, Livni E, Djaaldetti M, Pinkhas J. Gaucher's disease: a disease with chronic stimulation of the immune system. Arch Pathol Lab Med 1982; 106: 388-91.
22. Kluth DC, Rees AJ. Inhibiting inflammatory cytokines. Semin Nephrol 1996; 16: 576-82.
23. Liu B, Hong JS. Role of microglia in inflammation mediated neurodegenerative disease: mechanisms and strategies for therapeutic intervention. J Pharmacol Exp Ther 2003; 304: 1-7.
24. McGeer PL, Itagaki S, Boyes BE, McGeer EG. Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains. Neurology 1998; 38: 1285-91.
25. Raine CS. Multiple sclerosis: immune system molecule expression in the central nervous system. J Neuropathol Exp Neurol 1994; 53: 328-37.
26. Guzik TJ, Korbut R, Adamek-Guzik T. Nitric oxide and superoxide in inflammation and immune regulation. J Physiol Pharmalcol 2003; 54: 469-87.
27. Bogdan C. Nitric oxide and the immune response. Nat Immunol 2001; 2: 907-16.
28. Faber JL. Mechanisms of cell injury by activated oxygen species. Environ Health Perspect 1994; 102: 17-24.
29. Wang T, Qin L, Liu B, Liu Y, Wilson B, Eling TE, Langenbach R, Taniura S, Hong JS. Role of reactive oxygen species in LPS-induced production of prostaglandin E2 in microglia. J Neurochem 2004; 88: 939-47.
30. Lal MA, Brismar H, Eklof AC, Aperia A. Role of oxidative stress in advanced glycation end product-induced mesangial cell activation. Kidney Int 2002; 61: 2006-14.
31. Rosenberger J, Petrovics G, Buzas B. Oxidative stress induces proorphanin FQ and proenkephalin gene expression in astrocytes through p38- and ERK-MAP kinases and NF-kappaB. J Nerurochem 2001; 79: 35-44.
32. Myerowitz R, Lawson D, Mizukami H, Mi Y, Tifft CJ, Proia RL. Molecular pathophysiology in Tay-Sachs and Sandhoff diseases as revealed by gene expression profiling. Hum Mol Genet 2002; 11: 1343-50.
33. Wada R, Tifft CJ, Proia RL. Microglial activation precedes acute neurodegeneration in Sandhoff disease and is suppressed by bone marrow transplantation. Proc Natl Acad Sci USA 2000; 97: 10954-9.
34. Liu Y, Suzuki K, Reed JD, Grinberg A, Westphal H, Hoffmann A, Doring T, Sandhoff K, Proia RL. Mice with type 2 and 3 Gaucher disease point mutations generated by a single insertion mutagenesis procedure (SIMP). Proc Natl Acad Sci USA 1998; 95: 2503-8.
35. Xu YH, Quinn B, Witte D, Grabowski GA. Viable mouse models of acid beta-glucosidase deficiency: the defect in Gaucher disease. Am J Pathol 2003; 163: 2093-101.